Hologic (HOLX) Tops Q1 EPS by 3c; Bumps Outlook

Go back to Hologic (HOLX) Tops Q1 EPS by 3c; Bumps Outlook

Hologic (HOLX) PT Raised to $33 at Needham & Company on Strong Q1 Growth Acceleration

January 29, 2015 8:24 AM EST

Needham & Company analyst Mike Matson reiterated a Buy rating and boosted his price target on Hologic (NASDAQ: HOLX) to $33.00 (from $30.00) following broad-based growth acceleration in Q1.

Matson commented, "HOLX's F1Q15 revenue was consistent with its 1/12/15 preannouncement while EPS beat consensus. Management raised... More